These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1382864)

  • 21. Immunoregulatory role of CD40 in human B cell differentiation.
    Splawski JB; Fu SM; Lipsky PE
    J Immunol; 1993 Feb; 150(4):1276-85. PubMed ID: 7679424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of IgE and IgG1 in human B cell cultures with staphylococcal superantigens: role of helper T cell interaction, resistance to interferon-gamma.
    Armerding D; van Reijsen FC; Hren A; Mudde GC
    Immunobiology; 1993 Jul; 188(3):259-73. PubMed ID: 7693580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Failure of B cells in common variable immunodeficiency to transit from proliferation to differentiation is associated with altered B cell surface-molecule display.
    Saxon A; Giorgi JV; Sherr EH; Kagan JM
    J Allergy Clin Immunol; 1989 Jul; 84(1):44-55. PubMed ID: 2787815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-4 induces human B cell maturation and IgE synthesis in SCID-hu mice. Inhibition of ongoing IgE production by in vivo treatment with an IL-4/IL-13 receptor antagonist.
    Carballido JM; Schols D; Namikawa R; Zurawski S; Zurawski G; Roncarolo MG; de Vries JE
    J Immunol; 1995 Nov; 155(9):4162-70. PubMed ID: 7594571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin 8 (IL-8) selectively inhibits immunoglobulin E production induced by IL-4 in human B cells.
    Kimata H; Yoshida A; Ishioka C; Lindley I; Mikawa H
    J Exp Med; 1992 Oct; 176(4):1227-31. PubMed ID: 1383379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL-6 antisense oligonucleotides inhibit IgE production in IL-4 and anti-CD40-stimulated human B-lymphocytes.
    Björck P; Larsson S; Andäng M; Ahrlund-Richter L; Paulie S
    Immunol Lett; 1998 Mar; 61(1):1-5. PubMed ID: 9562370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of interleukin-10 on anti-CD40- and interleukin-4-induced immunoglobulin E production by human lymphocytes.
    Uejima Y; Takahashi K; Komoriya K; Kurozumi S; Ochs HD
    Int Arch Allergy Immunol; 1996 Jul; 110(3):225-32. PubMed ID: 8688668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mononuclear cells from patients with the hyper-IgE syndrome produce little IgE when they are stimulated with recombinant human interleukin-4.
    Claasen JJ; Levine AD; Schiff SE; Buckley RH
    J Allergy Clin Immunol; 1991 Nov; 88(5):713-21. PubMed ID: 1720150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin-4 suppresses immunoglobulin production by peripheral blood lymphocytes of patients with common variable immunodeficiency (CVI) induced by supernatants of T cell clones.
    Pastorelli G; Roncarolo MG; Touraine JL; Rousset F; Pene J; de Vries JE
    Clin Exp Immunol; 1989 Dec; 78(3):341-7. PubMed ID: 2575470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cross-linking surface Ig delays CD40 ligand- and IL-4-induced B cell Ig class switching and reveals evidence for independent regulation of B cell proliferation and differentiation.
    Rush JS; Hasbold J; Hodgkin PD
    J Immunol; 2002 Mar; 168(6):2676-82. PubMed ID: 11884432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of low concentrations of cadmium on immunoglobulin E production by human B lymphocytes in vitro.
    Jelovcan S; Gutschi A; Kleinhappl B; Sedlmayr P; Barth S; Marth E
    Toxicology; 2003 Jun; 188(1):35-48. PubMed ID: 12748040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of B cell dysfunction in patients with common variable immunodeficiency by using recombinant interleukin 2.
    Ariga T; Okano M; Takahashi Y; Sakiyama Y; Matsumoto S
    Tohoku J Exp Med; 1987 May; 152(1):53-61. PubMed ID: 3112997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term administration of 13-cis retinoic acid in common variable immunodeficiency: circulating interleukin-6 levels, B-cell surface molecule display, and in vitro and in vivo B-cell antibody production.
    Saxon A; Keld B; Braun J; Dotson A; Sidell N
    Immunology; 1993 Nov; 80(3):477-87. PubMed ID: 8288320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of LFA-1-dependent human B-cell aggregation induced by CD40 antibodies and interleukin-4 leads to decreased IgE synthesis.
    Björck P; Paulie S
    Immunology; 1993 Feb; 78(2):218-25. PubMed ID: 7682536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of lymphocyte differentiation in primary and secondary immunodeficiency diseases.
    Tedder TF; Crain MJ; Kubagawa H; Clement LT; Cooper MD
    J Immunol; 1985 Sep; 135(3):1786-91. PubMed ID: 3160779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endogenous IL-6 and IL-10 contribute to the differentiation of CD40-activated human B lymphocytes.
    Burdin N; Van Kooten C; Galibert L; Abrams JS; Wijdenes J; Banchereau J; Rousset F
    J Immunol; 1995 Mar; 154(6):2533-44. PubMed ID: 7533177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B cell activation via CD40 is required for specific antibody production by antigen-stimulated human B cells.
    Nonoyama S; Hollenbaugh D; Aruffo A; Ledbetter JA; Ochs HD
    J Exp Med; 1993 Sep; 178(3):1097-102. PubMed ID: 7688786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen.
    Rousset F; Garcia E; Banchereau J
    J Exp Med; 1991 Mar; 173(3):705-10. PubMed ID: 1705282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activated mast cells produce interleukin 13.
    Burd PR; Thompson WC; Max EE; Mills FC
    J Exp Med; 1995 Apr; 181(4):1373-80. PubMed ID: 7535336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An interleukin 4 (IL-4) mutant protein inhibits both IL-4 or IL-13-induced human immunoglobulin G4 (IgG4) and IgE synthesis and B cell proliferation: support for a common component shared by IL-4 and IL-13 receptors.
    Aversa G; Punnonen J; Cocks BG; de Waal Malefyt R; Vega F; Zurawski SM; Zurawski G; de Vries JE
    J Exp Med; 1993 Dec; 178(6):2213-8. PubMed ID: 7504061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.